Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench

Fig. 3

Expression of fibrosis-associated proteins in cardiomyocytes Cardiomyocytes in hypoglycemic conditions were treated with GW0742 (a PPARδ agonist). a PPARδ; b STAT3; c CTGF; and d MMP9. PPARδ peroxisome proliferator-activated receptor δ, STAT3 signal transducer and activator of transcription 3, CTGF connective tissue growth factor, MMP9 matrix metallopeptidase 9

Back to article page